Ribomic Inc. (TYO:4591)
Japan · Delayed Price · Currency is JPY 67.00
-2.00 (-2.90%)
Jun 3, 2026, 3:30 PM JST
Ribomic Market Cap
Ribomic has a market cap or net worth of 3.75 billion as of June 3, 2026. Its market cap has decreased by -2.28% in one year.
Market Cap
3.75B
Enterprise Value
920.31M
Revenue
3.00M
Ranking
n/a
PE Ratio
n/a
Stock Price
67.00
Market Cap Chart
Since September 25, 2014, Ribomic's market cap has decreased from 22.97B to 3.75B, a decrease of -83.69%. That is a compound annual growth rate of -14.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 2, 2026 | 3.75B | -9.03% |
| Dec 30, 2025 | 4.12B | 20.26% |
| Dec 30, 2024 | 3.43B | -11.13% |
| Dec 29, 2023 | 3.85B | -41.00% |
| Dec 30, 2022 | 6.53B | -43.16% |
| Dec 30, 2021 | 11.49B | 13.74% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CellSource | 6.33B |
| Noile-Immune Biotech | 5.80B |
| TMS Co., Ltd. | 5.78B |
| Chiome Bioscience | 5.38B |
| Kohjin Bio | 5.19B |
| PRISM BioLab Co.,LTD | 5.17B |
| Linical | 4.97B |
| D. Western Therapeutics Institute | 4.16B |